1
|
Mitsuhashi R, Song BS, Inoue K, Asano T, Noda S. Design and fabrication of a coupled high-Q photonic nanocavity system with large coupling coefficients. Opt Express 2024; 32:10630-10647. [PMID: 38571269 DOI: 10.1364/oe.513508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/16/2024] [Accepted: 02/27/2024] [Indexed: 04/05/2024]
Abstract
In a previous work, we demonstrated a coupled cavity system where photons in one storage cavity can be transferred to another storage cavity at an arbitrary time by applying a voltage pulse to a third cavity placed in a p-i-n junction. In this work, we demonstrate methods to improve the transfer efficiency and photon lifetimes of such a coupled system. Firstly, we designed a photonic-crystal structure that achieves a large coupling coefficient without reducing the radiation quality factor compared to the previously proposed structure: The photonic-crystal design was changed to a more symmetric configuration to suppress radiation losses and then optimized using an automatic structure tuning method based on the Covariance Matrix Adaptive Evolutional Strategy (CMAES). Here we added two improvements to achieve an evolution toward the desired direction in the two-dimensional target parameter space (spanned by the coupling coefficient and the inverse radiation loss). Secondly, to improve the experimental cavity quality factors, we developed a fabrication process that reduces the surface contamination associated with the fabrication of the p-i-n junction: We covered the photonic structure with a SiO2 mask to avoid the contamination and the electrode material was changed from Al to Au/Cr to enable cleaning by a weak acid. Owing to these improvements of the cavity design and the fabrication process, the obtained system provides coupling strengths that are about three times stronger and photon lifetimes that are about two times longer, compared to the previously reported system.
Collapse
|
2
|
Noda S, Hanai S, Ito R, Kobayashi Y, Nakagomi D. Isolated thoracic aortitis following mRNA vaccination against SARS-CoV-2. QJM 2023; 116:875-876. [PMID: 37294845 DOI: 10.1093/qjmed/hcad126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Indexed: 06/11/2023] Open
Affiliation(s)
- S Noda
- Department of Rheumatology and Department of Diabetes and Endocrinology, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan
| | - S Hanai
- Department of Rheumatology, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan
| | - R Ito
- Department of Rheumatology, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan
| | - Y Kobayashi
- Department of Rheumatology, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan
| | - D Nakagomi
- Department of Rheumatology, University of Yamanashi Hospital, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan
| |
Collapse
|
3
|
Kuramoto M, Kawashima N, Tazawa K, Nara K, Fujii M, Noda S, Hashimoto K, Nozaki K, Okiji T. Mineral trioxide aggregate suppresses pro-inflammatory cytokine expression via the calcineurin/nuclear factor of activated T cells/early growth response 2 pathway in lipopolysaccharide-stimulated macrophages. Int Endod J 2020; 53:1653-1665. [PMID: 32767860 DOI: 10.1111/iej.13386] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 06/27/2020] [Accepted: 08/04/2020] [Indexed: 11/27/2022]
Abstract
AIM To elucidate mechanisms by which mineral trioxide aggregate (MTA) suppresses pro-inflammatory cytokine mRNA expression in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. METHODOLOGY Mineral trioxide aggregate extracts were prepared by immersing set ProRoot MTA in culture medium. RAW264.7 cells were cultured in the presence of LPS and MTA extracts. mRNA expression levels of interleukin (IL)-1α, IL-6, early growth response 2 (Egr2), suppressor of cytokine signalling 3 (Socs3) and IL-10 were quantified with reverse transcription-quantitative polymerase chain reaction. Phosphorylation of nuclear factor-kappa B (NF-κB) p65 in RAW264.7 cells was analysed by Western blotting. Intracellular calcium imaging was performed with Fluo-4 AM. The activity of nuclear factor of activated T cells (NFAT) was determined by luciferase assays. Enforced expression and silencing of Egr2 in RAW264.7 cells were carried out using an expression vector and specific RNAi, respectively. In vivo kinetics of Egr2+ cells in MTA-treated rat molar pulp tissues were examined using immunohistochemistry. Data were analysed by one-way analysis of variance, followed by the Tukey-Kramer test (P < 0.05). RESULTS Exposure to MTA extracts resulted in reduced mRNA expression levels of IL-1α and IL-6, as well as reduced expression of phosphorylated NF-κB, in LPS-stimulated RAW264.7 cells. Exposure to MTA extracts induced Ca2+ influx, which was blocked by NPS2143, an antagonist of calcium-sensing receptor (CaSR); Ca2+ influx then triggered activation of calcineurin/NFAT signalling and enhanced mRNA expression of Egr2. Enforced expression of Egr2 in RAW264.7 cells promoted the expression of both IL-10 and Socs3. In vivo application of MTA onto rat molar pulp tissue resulted in the appearance of Egr2-expressing cells that coexpressed CD163, a typical M2 macrophage marker. CONCLUSIONS Mineral trioxide aggregate extracts induced downregulation of IL-1α and IL-6 in LPS-stimulated RAW264.7 cells via CaSR-induced activation of calcineurin/NFAT/Egr2 signalling and subsequent upregulation of IL-10 and Socs3.
Collapse
Affiliation(s)
- M Kuramoto
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - N Kawashima
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - K Tazawa
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - K Nara
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - M Fujii
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - S Noda
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - K Hashimoto
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - K Nozaki
- Department of Restorative Sciences, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| | - T Okiji
- Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan
| |
Collapse
|
4
|
Fujii M, Kawashima N, Tazawa K, Hashimoto K, Nara K, Noda S, Nagai S, Okiji T. Hypoxia‐inducible factor 1α promotes interleukin 1β and tumour necrosis factor α expression in lipopolysaccharide‐stimulated human dental pulp cells. Int Endod J 2020; 53:636-646. [DOI: 10.1111/iej.13264] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2019] [Accepted: 12/31/2019] [Indexed: 12/30/2022]
Affiliation(s)
- M. Fujii
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| | - N. Kawashima
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| | - K. Tazawa
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| | - K. Hashimoto
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| | - K. Nara
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| | - S. Noda
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| | - S. Nagai
- Division of Oral Health Sciences Department of Molecular Immunology Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) Tokyo Japan
| | - T. Okiji
- Division of Oral Health Sciences Department of Pulp Biology and Endodontics Graduate School of Medical and Dental Sciences Tokyo Medical and Dental University (TMDU) TokyoJapan
| |
Collapse
|
5
|
Inoue T, Yoshida M, Zoysa MD, Ishizaki K, Noda S. Design of photonic-crystal surface-emitting lasers with enhanced in-plane optical feedback for high-speed operation. Opt Express 2020; 28:5050-5057. [PMID: 32121733 DOI: 10.1364/oe.385277] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Accepted: 01/27/2020] [Indexed: 05/27/2023]
Abstract
Photonic-crystal surface-emitting lasers (PCSELs) use the two-dimensional (2D) resonance at the band-edge of a photonic crystal for lasing, and they feature various outstanding functionalities such as high-brightness lasing, arbitrary shaping of beam patterns and on-chip 2D beam steering. In this paper, to investigate the applicability of PCSELs for high-speed operation, we design PCSELs with enhanced in-plane optical feedback, which enable single-mode lasing inside a circular region the diameter of which is less than 10 µm. To realize a strong in-plane confinement of the lasing mode, we increase the one-dimensional coupling coefficients between counter-propagating waves through the careful design of the lattice points. We also introduce an in-plane heterostructure composed of two photonic crystals with different photonic bandgaps and utilize reflection at the boundary of the two photonic crystals in addition to the optical feedback at the band-edge of each photonic crystal. By using three-dimensional finite-difference time-domain method (3D-FDTD), we confirm that the proposed hetero-PCSELs can achieve single-mode lasing operation inside a 9-µm-diameter and possibly realize a 3-dB modulation bandwidth larger than 40 GHz.
Collapse
|
6
|
Kashiwagi S, Asano Y, Kouhashi R, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M. Validation of the optimum timing of assessment of tumour infiltrating lymphocytes during preoperative chemotherapy for breast cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz416.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
7
|
Asano Y, Kashiwagi S, Kouhashi R, Ishihara S, Tauchi Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M. Verification of metabolic regulatory mechanisms in androgen receptor-positive triple negative breast cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz417.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
8
|
Khattri S, He H, Noda S, Asano Y, Sato S, Han J, Pavel A, Krueger J, Guttman-Yassky E. 425 RNA-seq transcriptomic profiling of diffuse and limited cutaneous systemic sclerosis. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Suzuki Y, Okonogi N, Sato H, Oike T, Yoshimoto Y, Mimura K, Noda S, Okamoto M, Tamaki T, Morokoshi Y, Hasegawa S, Ohgaki H, Yokoo H, Nakano T. EP-2163 Combination therapy of microglia and radiotherapy in a rat model of spontaneous glioma. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32583-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Dote S, Ito K, Itakura S, Yasu T, Hira D, Noda S, Yamada S, Kobayashi Y, Terada T. Impact of prior bortezomib therapy on the incidence of lenalidomide-induced skin rash in multiple myeloma: A propensity score-matched multi-institutional cohort study. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy286.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Noda S, Yonemori K, Shirakawa N, Okuma H, Shimizu T, Hirakawa A, Shibata T, Sukigara T, Okita N, Kawai A, Yamamoto N, Nakamura K, Mano H, Nishida T, Fujiwara Y. MASTER KEY project: A basket/umbrella trial for rare cancers in Japan. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy279.436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Temirgaliyeva T, Kuzuhara S, Noda S, Nazhipkyzy M, Kerimkulova A, Lesbayev B, Prikhodko N, Mansurov Z. Self-Supporting Hybrid Supercapacitor Electrodes Based on Carbon Nanotube and Activated Carbons. Eurasian Chem Tech J 2018. [DOI: 10.18321/ectj719] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Self-supporting AC (activated carbon)-FWCNT (few-wall carbon nanotubes) hybrid electrodes were fabricated by mixing of ACs with high specific surface area (SSA) and sub-millimeter-long FWCNTs. In order to fabricate the hybrid electrodes, AC and FWCNT were mixed in a weight ratio of 9:1, dispersed by bath-sonication and vacuum-filtrated on a membrane filter. The addition of FWCNTs gives conductivity and mechanical strength, and replace metallic current collectors in thick (0.1 mm) electrodes. For making an electrode, three different ACs that derived from walnut shell (WS), that from apricot stones (AS), and that commercially used for capacitors (YP-80F, Kuraray Chemical Co., Osaka Japan), were used with FWCNT in weight ratio of AC:FWCNT = 9:1. An electrode based only on FWCNT was also prepared as a reference for comparison. Electrochemical properties of the obtained electrodes were investigated by the cyclic voltammetry method (CV). Electrochemical characteristics were measured using the three-electrode cell contained of YP80F-FWCNT, AS-FWCNT, WS-FWCNT as a working electrode, a YP-80F-FWCNT counter electrode and a Ag/AgCl reference electrode with an electrolyte of 1 M Na2SO4 aqueous solution. Also, the morphological properties of obtained electrodes were studied using scanning electron microscope (SEM), the SSA was investigated by the Brunauer-Emmett-Teller analysis. SSA, conductivity, and resistivity of AS-FWCNT and WS-FWCNT electrodes were summarized. Both the AS-FWCNT and WS-FWCNT hybrid electrodes showed specific capacitances of about 140 F/g at 1 mV/s and about 100 F/g at 100 mV/s, which are similar or even better than the AC-CNT hybrid electrode made of commercialized AC (YP-80F).
Collapse
|
13
|
Malik K, Czarnowicki T, Wen H, Noda S, Pavel A, Nakajima S, Honda T, Shin J, Lee H, Krueger J, Lee K, Kabashima K, Guttman-Yassky E. 555 Integrating serum and skin biomarkers to assess disease extent beyond clinical scores, advancing precision therapeutics. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
14
|
Kinoshita M, Takechi K, Nagao Y, Izumi S, Arai Y, Shirono R, Iwamoto S, Takao S, Noda S, Ueno J, Harada M. Abstract No. 694 The impact of virtual liver parenchymal perfusion using existing 3-dimensional workstation and simulation software in conventional transcatheter arterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2018. [DOI: 10.1016/j.jvir.2018.01.739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
15
|
Kashiwagi S, Asano Y, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Hirakawa K, Ohira M. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes within fibrotic foci of tumor stroma (FF-TILs). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx655.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
Takada K, Kashiwagi S, Goto W, Asano Y, Takashima T, Morisaki T, Noda S, Onoda N, Hirakawa K, Ohira M. Biomarker analysis of TPD regimen (trastuzumab, ertuzumab and docetaxel) for advanced HER2-positive breast cancer by HER family expression. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx653.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
17
|
Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Noda S, Takashima T, Onoda N, Tomita S, Hirakawa K, Ohira M. Predictive value of the improvement in tumor microenvironment for progression in breast cancer patients treated with neoadjuvant chemotherapy. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Makihara R, Maeda M, Itahashi K, Noda S, Sato J, Murakami S, Goto Y, Kanda S, Fujiwara Y, Horinouchi H, Tsukamoto T, Hashimoto H, Makino Y, Yamamoto N, Ohe Y, Terakado H. Dried plasma spot assay for sunitinib and its active metabolite by high performance liquid chromatography tandem mass spectrometry. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx678.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Kimura S, Nakanishi H, Noda S, Murakami A, Iijima M, Koike H, Katsuno M. Diagnostic value of muscle biopsy for neuromuscular diseases. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.3543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
20
|
Takemoto H, Fukushima R, Ishii S, Endo R, Koyama Y, Saito K, Noda S, Mihara C, Yamaguchi M, Kotani J. SUN-P229: Nutritional Status of Cancer Patients Seen from Nutritionday Oncology in Japan 2015. Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30399-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
21
|
Wen H, Malik K, Noda S, Ungar B, Suprun M, Nakajima S, Honda T, Lee H, Suarez-Farinas M, Krueger J, Kabashima K, Lee K, Guttman-Yassky E. 298 RNA-seq profiling highlights the robust inflammation and Th17-skewing of the non-lesional Asian atopic dermatitis phenotype. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
22
|
Goto W, Kashiwagi S, Asano Y, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Abstract P6-09-25: Circulating tumor cell clusters-associated gene plakoglobin is a novel prognostic predictor in patients with breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-09-25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Accumulating evidence shows that circulating tumor cells (CTC) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. It was reported that CTC clusters (CTCc) have more metastatic potential than single CTC. Lately, studies also show that the high expression of plakoglobin, a cell adhesion protein, within the primary tumor are positively associated with CTCc in breast cancer patients. In addition, it is thought that insufficient expression of plakoglobin could promote epithelial-mesenchymal transition (EMT). In this study, we investigated the correlation between plakoglobin expression and survival of breast cancer.
Materials and Methods:A total of 126 patients with resectable early-stage breast cancer were treated with neoadjuvant chemotherapy (NAC). All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. The expression of plakoglobin were identified by immunohistochemical staining properties in cell membrane. Staining with plakoglobin (clone 4C12) was scored according to the percentage of cells that stained positively: low, 0-25%; medium, 26-75%; high, >75%. We investigated the correlation between the plakoglobin expression in primary tumor specimen and clinical outcomes including overall-survival (OS), disease-free-survival (DFS), distant-metastasis-free-survival (DMFS), the efficacy of NAC. And we examined the relation between the expression of plakoglobin and E-cadherin, EMT marker.
Results: The patient with high plakoglobin expression had significantly worse OS (p=0.021, log-rank) and DFS (p=0.015, log-rank), DMFS (p=0.040, log-rank). And the plakoglobin expression had no correlation with pathological complete response (pCR) rate (p=0.596). Also, there was not a statistically significant relationship between the plakoglobin expression and other clinicopathological parameters including tumor size (p=0.708), lymph node status (p=0.479), subtype (p=0.413), nuclear grade (p=0.642), Ki67 (p=0.202), tumor infiltrating lymphocytes (p=0.828). On univariate analysis with respect to distal metastasis, high plakoglobin expression showed worse prognosis than low plakoglobin expression (p=0.013, hazard ratio=4.221). And multivariate analysis found the same result (p=0.015, hazard ratio=4.070). In addition, there was a significant relationship between the expression of plakoglobin and E-cadherin (p=0.023).
Conclusions: Plakoglobin expression is an independent prognostic factor in the patients with breast cancer; particularly for DMFS, and this mechanism related to EMT.Background: Accumulating evidence shows that circulating tumor cells (CTC) are linked to metastatic relapse and are regarded as a prognostic marker for human cancer. It was reported that CTC clusters (CTCc) have more metastatic potential than single CTC. Lately, studies also show that the high expression of plakoglobin, a cell adhesion protein, within the primary tumor are positively associated with CTCc in breast cancer patients. In addition, it is thought that insufficient expression of plakoglobin could promote epithelial-mesenchymal transition (EMT). In this study, we investigated the correlation between plakoglobin expression and survival of breast cancer.
Materials and Methods:A total of 126 patients with resectable early-stage breast cancer were treated with neoadjuvant chemotherapy (NAC). All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. The expression of plakoglobin were identified by immunohistochemical staining properties in cell membrane. Staining with plakoglobin (clone 4C12) was scored according to the percentage of cells that stained positively: low, 0-25%; medium, 26-75%; high, >75%. We investigated the correlation between the plakoglobin expression in primary tumor specimen and clinical outcomes including overall-survival (OS), disease-free-survival (DFS), distant-metastasis-free-survival (DMFS), the efficacy of NAC. And we examined the relation between the expression of plakoglobin and E-cadherin, EMT marker.
Results: The patient with high plakoglobin expression had significantly worse OS (p=0.021, log-rank) and DFS (p=0.015, log-rank), DMFS (p=0.040, log-rank). And the plakoglobin expression had no correlation with pathological complete response (pCR) rate (p=0.596). Also, there was not a statistically significant relationship between the plakoglobin expression and other clinicopathological parameters including tumor size (p=0.708), lymph node status (p=0.479), subtype (p=0.413), nuclear grade (p=0.642), Ki67 (p=0.202), tumor infiltrating lymphocytes (p=0.828). On univariate analysis with respect to distal metastasis, high plakoglobin expression showed worse prognosis than low plakoglobin expression (p=0.013, hazard ratio=4.221). And multivariate analysis found the same result (p=0.015, hazard ratio=4.070). In addition, there was a significant relationship between the expression of plakoglobin and E-cadherin (p=0.023).
Conclusions: Plakoglobin expression is an independent prognostic factor in the patients with breast cancer; particularly for DMFS, and this mechanism related to EMT.
Citation Format: Goto W, Kashiwagi S, Asano Y, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Circulating tumor cell clusters-associated gene plakoglobin is a novel prognostic predictor in patients with breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P6-09-25.
Collapse
Affiliation(s)
- W Goto
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Kashiwagi
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Y Asano
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Takada
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Takashima
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Morisaki
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Noda
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - N Onoda
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohsawa
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Hirakawa
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohira
- Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
23
|
Kashiwagi S, Asano Y, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Abstract P3-04-20: Predicting therapeutic effect by on tumor invasion lymphocytes (TILs) in endocrine therapy for stage IV breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p3-04-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Breast cancer with distant metastasis at first presentation (stage IV disease) is often encountered in the outpatient department. With recent advances in multimodal therapies for breast cancer, long-term survival can now be expected even in stage IV breast cancer with distant metastasis. However, a goal in treating metastatic disease is prolongation of survival while maintaining good quality of life (QOL). Endocrine therapy is suitable for this purpose.The tumor immune environment not only modulates the effects of immunotherapy, but also the effects of other anticancer drugs and treatment outcomes. These immune responses can be evaluated with tumor-infiltrating lymphocytes (TILs), which has frequently been verified clinically. In the present study, we hypothesized that TILs would be useful as predictive marker of the therapeutic effect in endocrine therapy as well. In this study, the prediction of the therapeutic effect by TILs in endocrine therapy for stage IV breast cancer was clinically verified.
Materials and Methods:Data from 40 patients who underwent endocrine therapy as the initial drug therapy for stage IV breast cancer were used. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of endocrine therapy, was investigated retrospectively. Patients with 350% lymphocytic infiltration were considered to have lymphocyte-predominant breast cancer (LPBC).
Results:Among all 40 patients, TIL levels were high in 13 (32.5%) and low in 27 (67.5%) patients. Nine patients (22.5%) had LPBC, and 31 patients (77.5%) had non-LPBC. Investigation of the clinical pathological features of patients showed no significant differences between the high TIL and low TIL groups. There were also no significant differences between LPBC and non-LPBC patients. An analysis of outcomes comparing the high TIL and low TIL groups showed no prolongation in progression-free survival (PFS) (p=0.171, log-rank), time to treatment failure (TTF)(p=0.054), or overall survival (OS) (p=0.641). LPBC patients had significant prolongations of PFS (p=0.005), TTF (p=0.001), and OS (p=0.027) compared to non-LPBC patients. On receiver operating characteristic (ROC) curve analyses, results were better with LPBC (AUC: 0.700) than with TILs (AUC: 0.606).
Conclusion: The present findings suggest that a high level of lymphocytic infiltration in the tumor stroma may serve as a predictor of the therapeutic effect of endocrine therapy for patients with stage IV ER-positive breast cancer.
Citation Format: Kashiwagi S, Asano Y, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Predicting therapeutic effect by on tumor invasion lymphocytes (TILs) in endocrine therapy for stage IV breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P3-04-20.
Collapse
Affiliation(s)
- S Kashiwagi
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Y Asano
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - W Goto
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Takada
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Takashima
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Morisaki
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Noda
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - N Onoda
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohsawa
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Hirakawa
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohira
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
24
|
Asano Y, Kashiwagi S, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Abstract P2-05-05: Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p2-05-05] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The tumor immune environment not only modulates the effects of immunotherapy, but also the effects of other anticancer drugs and treatment outcomes. Thus, the importance of inhibiting and improving the tumor immune microenvironment is now recognized. These immune responses can be evaluated with tumor-infiltrating lymphocytes (TILs), which has frequently been verified clinically. On the other hand, residual cancer burden (RCB) evaluation has been shown to be a useful predictor of survival after neoadjuvant chemotherapy (NAC). In this study, RCB and TILs evaluations were combined to produce an indicator that we have termed “RCB-TILs”, and its clinical application to NAC for breast cancer was verified by subtype-stratified analysis.
Materials and Methods:A total of 177 patients with resectable early-stage breast cancer were treated with NAC.The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of NAC, was investigated retrospectively. The RCB was calculated using the Residual Cancer Burden Calculator on the website of the MD Anderson Cancer Center. The RCB and TILs evaluations were combined to create the “RCB-TILs”. Patients who were RCB-positive and had high TILs were considered RCB-TILs-positive, and all other combinations were RCB-TILs-negative.
Results: Univariable analysis of patients with high TILs found that this contributed significantly to prolonging DFS in all patients (p = 0.022, hazard ratio = 0.420), TNBC patients (p = 0.004, hazard ratio = 0.177), and HER2BC patients (p = 0.026, hazard ratio = 0.123). For HRBC patients, however, high TILs did not contribute to survival (p = 0.990, hazard ratio = 0.992). Being RCB-TILs-positive, however, contributed significantly to prolonging DFS in all patients (p < 0.001, hazard ratio = 0.181), TNBC patients (p < 0.001, hazard ratio = 0.099), HER2BC patients (p = 0.026, hazard ratio = 0.123), and HRBC patients (p = 0.039, hazard ratio = 0.258). On multivariable analysis, being RCB-TILs-positive was an independent factor for recurrence after NAC in all patients (p < 0.001, hazard ratio = 0.048), TNBC patients (p = 0.018, hazard ratio = 0.041), HER2BC patients (p = 0.036, hazard ratio = 0.134), and HRBC patients (p = 0.002, hazard ratio = 0.081).
Conclusion: The results of the present study suggest that RCB-TILs is a significant predictor for breast cancer recurrence after NAC and may be a more sensitive indicator than TILs alone.
Citation Format: Asano Y, Kashiwagi S, Goto W, Takada K, Takashima T, Morisaki T, Noda S, Onoda N, Ohsawa M, Hirakawa K, Ohira M. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes (TILs) and residual cancer burden (RCB) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-05.
Collapse
Affiliation(s)
- Y Asano
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Kashiwagi
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - W Goto
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Takada
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Takashima
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Morisaki
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Noda
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - N Onoda
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohsawa
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Hirakawa
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohira
- Osaka City University Graduate School of Medicine, Osaka, Japan; Deaprtment of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
25
|
Ye D, Ahn H, Pu YS, Weiqing H, Xie LP, Huang SP, Wu HC, Ma L, Yamada S, Noda S, Sun Y. Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naïve patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw372.33] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
Asano Y, Kashiwagi S, Goto W, Kurata K, Noda S, Takashima T, Onoda N, Tanaka S, Ohsawa M, Hirakawa K. Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer. Br J Surg 2016; 103:845-54. [PMID: 26953091 DOI: 10.1002/bjs.10127] [Citation(s) in RCA: 76] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2015] [Revised: 09/22/2015] [Accepted: 01/08/2016] [Indexed: 12/19/2022]
Abstract
BACKGROUND Tumour-infiltrating lymphocytes (TILs) can be used to monitor the immune response, and are important in predicting treatment responses and outcomes for various types of cancer. Recently, specific TIL subsets have been reported to be clinically useful in predicting treatment responses. The CD8+/FOXP3+ TIL ratio (CFR) may be a more sensitive indicator for monitoring immune function. This study investigated the clinical significance and value of CFR as a biomarker to predict treatment responses to neoadjuvant chemotherapy for breast cancer. METHODS Patients with resectable early-stage breast cancer treated with neoadjuvant chemotherapy at Osaka City University Hospital, Japan, between 2007 and 2013 were included. Oestrogen receptor, progesterone receptor, human epidermal growth factor receptor (HER) 2, Ki-67, CD8 and FOXP3 status were assessed by immunohistochemistry, and correlated with pathological complete response (pCR). RESULTS A total of 177 patients were included, of whom 90 had a high CFR and 87 a low CFR. Triple-negative breast cancer (TNBC) was more common in the high-CFR group than in the low-CFR group (46 versus 23 per cent; P = 0·002), as was HER2-enriched breast cancer (HER2BC) (27 versus 14 per cent; P = 0·033). Among these patients, the pCR rate was significantly higher in the high-CFR group than in the low-CFR group (TNBC: P = 0·022; HER2BC: P < 0·001). In multivariable analysis high-CFR status was an independent predictor of a favourable prognosis: hazard ratio 0·24 (95 per cent c.i. 0·05 to 0·72; P = 0·015) for TNBC and 0·10 (0·10 to 0·90; P = 0·041) for HER2BC. CONCLUSION The CFR may be a useful biomarker to predict treatment response to neoadjuvant therapy in aggressive breast cancer subtypes, such as TNBC and HER2BC.
Collapse
Affiliation(s)
- Y Asano
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Kashiwagi
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - W Goto
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Kurata
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Noda
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Takashima
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - N Onoda
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Tanaka
- Departments of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - M Ohsawa
- Departments of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Hirakawa
- Departments of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
27
|
Kashiwagi S, Asano Y, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Abstract P3-07-33: Prediction of the treatment response to neoadjuvant chemotherapy in breast cancer by subtypes using tumor-infiltrating lymphocytes. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-07-33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: Monitoring the host immunological response to cancer in the microenvironment of the interaction between tumor and the body plays an important role in predicting treatment response and outcomes. Recent interest has focused on the morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) and on the evidence showing their clinical relevance. Meanwhile, no consensus has yet been reached on standard methods for pathological evaluation of TILs. Therefore, methods of evaluation have differed in reports to date showing the clinical relevance of TILs. An International Working Group (2014) announced recommendations for evaluating TILs in an effort to improve consistency and reproducibility. In this study, the clinical validity and utility of TILs in NAC were investigated based on this recommendation with a stratified analysis by BC subtypes. Changes in TILs after recurrence, which have seldom been reported to date, are also discussed.
Experimental Design: TILs was evaluated in 177 patients with breast cancer treated with NAC and subsequent curative surgery. All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. Forty-five patients had HER2-positive breast cancer and were additionally administered weekly (2 mg/kg) or tri-weekly (6 mg/kg) trastuzumab during paclitaxel treatment. The correlation between TILs evaluated according to the standard method, and prognosis, including the efficacy of NAC, was investigated retrospectively.
Results: In the 96 high-TIL group, compared to the 81 low-TIL group, triple-negative breast cancer (TNBC) (p < 0.001) and HER2-enriched (p = 0.040) were significantly more frequent, and the pathological complete response (pCR) rate were significantly higher (p = 0.003). On multivariate analysis also demonstrated that high-TIL status was an independent factor to indicate significantly more favorable prognosis of the patients compared with low-TIL status (p = 0.036, HR = 0.45). Among the 61 TNBC and the 36 HER2-enriched patients, the pCR rate was significantly higher in the high-TIL group than in the low-TIL group (p = 0.013) (p = 0.014). On multivariate analysis also showed that high-TIL status was an independent factor to predict the favorable prognosis (p = 0.023, HR = 0.24) (p = 0.036, HR = 0.13). Biopsy specimens from local recurrence after successful NAC frequently showed decreased TILs.
Conclusion: TILs may be a biomarker to predict treatment response to NAC in patients with TNBC and HER2-enriched subtypes of BC. A decrease in TILs may also be associated with tumor recurrence.
Citation Format: Kashiwagi S, Asano Y, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Prediction of the treatment response to neoadjuvant chemotherapy in breast cancer by subtypes using tumor-infiltrating lymphocytes. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-07-33.
Collapse
Affiliation(s)
- S Kashiwagi
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Y Asano
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - W Goto
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Morisaki
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Noda
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Takashima
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - N Onoda
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Hirakawa
- Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
28
|
Asano Y, Kashiwagi S, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Abstract P4-04-14: Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p4-04-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: "Avoiding immune destruction" has recently been established as one of the hallmarks of cancer. The programmed cell death (PD)-1/programmed cell death-ligand (PD-L) 1 pathway is also an important immunosuppression mechanism that allows cancer cells to escape host immunity. The effect of the tumor immune environment not only on immunotherapy effectiveness, but also on conventional anti-tumor therapy effectiveness and prognosis, has recently been demonstrated. Thus, improvement of the tumor immune environment is important. In other words, the tumor immune environment plays a role in the anti-tumor effects of conventional anti-tumor drugs. Moreover, immune checkpoint proteins such as PD-1, PD-L1, and PD-L2 may play an important role in improving the tumor immune environment. Given this background, the clinical significance of immune checkpoint protein expression was investigated in patients receiving neoadjuvant chemotherapy (NAC) for breast cancer using conventional anti-cancer drugs, and whether this would be useful as a marker to predict treatment response was evaluated.
Experimental Design: A total of 177 patients with resectable early-stage breast cancer were treated with NAC. All patients received a standardized protocol of NAC consisting of four courses of FEC100 (500 mg/m2 fluorouracil, 100 mg/m2 epirubicin, and 500 mg/m2 cyclophosphamide) every 3 weeks, followed by 12 courses of 80 mg/m2 paclitaxel administered weekly. Forty-five patients had HER2-positive breast cancer and were additionally administered weekly (2 mg/kg) or tri-weekly (6 mg/kg) trastuzumab during paclitaxel treatment. ER, PR, HER2, Ki67, PD-L1, PDL-2 and PD-1 status were assessed by immunohistochemistry on core needle biopsy specimens.
Results: There were 37 (20.9%) patients with high PD-1 expression, 42 (23.7%) patients had high PD-L1 expression, and 52 (29.4%) patients had high PD-L2 expression. The patients with high PD-1 and PD-L1 expressions had a significantly higher rate of triple-negative breast cancer (TNBC) (p=0.041) (p<0.001). Univariate analysis showed that PD-1 and PD-L1 expressions were associated with significantly shorter DFS (p=0.008, HR=2.752) (p=0.002, HR=3.194). However, although multivariate analysis showed that lymph node metastases were an independent poor prognostic factor (p=0.046, HR=4.330), PD-1 and PD-L1 expressions were not independent prognostic factors (p=0.492, HR=1.415) (p=0.084, HR=2.613). In TNBC, patients with high PD-1 and PD-L1 expressions had significantly higher rates of non-pCR (p=0.003) (p<0.001). Univariate analysis showed that PD-1 and PD-L1 expressions also significantly shortened disease free survival in TNBC (p=0.048, HR=3.318) (p=0.007, HR=8.375). However, multivariate analysis found that only PD-L1 expression was an independent prognostic factor (p=0.041, HR=9.479).
Conclusions: PD-1 and PD-L1 expressions may be useful as biomarkers to predict treatment responses to NAC in breast cancer. Above all, PD-L1 expression may also be useful as biomarkers for more effective chemotherapy in TNBC.
Citation Format: Asano Y, Kashiwagi S, Goto W, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K. Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P4-04-14.
Collapse
Affiliation(s)
- Y Asano
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Kashiwagi
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - W Goto
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Morisaki
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - S Noda
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - T Takashima
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - N Onoda
- Osaka City University Graduate School of Medicine, Osaka, Japan
| | - K Hirakawa
- Osaka City University Graduate School of Medicine, Osaka, Japan
| |
Collapse
|
29
|
Yamasaki Y, Hasegawa K, Osawa T, Noda S. Rapid vapour deposition and in situ melt crystallization for 1 min fabrication of 10 μm-thick crystalline silicon films with a lateral grain size of over 100 μm. CrystEngComm 2016. [DOI: 10.1039/c6ce00122j] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
30
|
Noda S, Goto Y, Hayashi M, Aikawa H, Itahashi K, Kanda S, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Hamada A, Ohe Y. 449P Distribution of erlotinib to brain, tumor lesion and normal tissue analyzed by matrix assisted laser desorption/ionization mass spectrometry imaging and liquid chromatography-tandem mass spectrometry. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv532.33] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
31
|
Ono M, Kojima A, Shirahashi M, Noda S, Akiba Y, Nishijima S, Amagata T, Ikeda T, Yakubo K, Fukuiya T. Short, severe dizziness attacks in a pregnant woman with type I ARNOLD-Chiari malformation. J OBSTET GYNAECOL 2015; 36:430-1. [PMID: 26467350 DOI: 10.3109/01443615.2015.1090419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- M Ono
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - A Kojima
- b Department of Neurosurgery , Saitama City Hospital , Midori, Saitama , Japan
| | - M Shirahashi
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - S Noda
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - Y Akiba
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - S Nishijima
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - T Amagata
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - T Ikeda
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - K Yakubo
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| | - T Fukuiya
- a Department of Obstetrics and Gynaecology , Midori, Saitama , Japan
| |
Collapse
|
32
|
Nishimura S, Takashima T, Kawajiri H, Kashiwagi S, Noda S, Tokunaga S, Tei S, Yamagata S, Sunami T, Tezuka K, Ikeda K, Mizuyama Y, Ogawa Y, Onoda N, Nishimori T, Ishikawa T, Kudo S, Takada M, Hirakawa K. 1859 Clinical effects of prior chemotherapy on eribulin: Update and subgroup analysis of phase 2 multicenter single arm study of eribulin mesylate as first-line therapy for HER2 negative locally advanced or metastatic breast cancer. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30809-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
33
|
Kurata K, Onoda N, Noda S, Kashiwagi S, Asano Y, Takashima T, Hirakawa K. 2824 Efficacy of B-raf and MEK inhibitor on human anaplastic thyroid cancer cell lines. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31566-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Akiba Y, Ono M, Shirahashi M, Noda S, Nishijima S, Amagata T, Kusano R, Fuke T, Hayashida S, Ikeda T, Yakubo K, Fukuiya T. Polyhydramnios associated with Prader-Willi syndrome. J OBSTET GYNAECOL 2015; 35:752-3. [PMID: 26291428 DOI: 10.3109/01443615.2015.1005586] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Y Akiba
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - M Ono
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - M Shirahashi
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - S Noda
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - S Nishijima
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - T Amagata
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - R Kusano
- b Department of Neonatology , Saitama City Hospital , Midori, Saitama , Japan
| | - T Fuke
- b Department of Neonatology , Saitama City Hospital , Midori, Saitama , Japan
| | - S Hayashida
- b Department of Neonatology , Saitama City Hospital , Midori, Saitama , Japan
| | - T Ikeda
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - K Yakubo
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| | - T Fukuiya
- a Department of Obstetrics and Gynaecology , Saitama City Hospital , Midori, Saitama , Japan
| |
Collapse
|
35
|
Akiba Y, Ono M, Shirahashi M, Noda S, Nishijima S, Amagata T, Kusano R, Fuke T, Hayashida S, Ikeda T, Yakubo K, Fukuiya T. Polyhydramnios associated with Prader-Willi syndrome. J OBSTET GYNAECOL 2015:1-2. [PMID: 26271012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Affiliation(s)
- Y Akiba
- Department of Obstetrics and Gynaecology, Saitama City Hospital , Midori, Saitama , Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Furuta T, Maeyama T, Ishikawa KL, Fukunishi N, Fukasaku K, Takagi S, Noda S, Himeno R, Hayashi S. Comparison between Monte Carlo simulation and measurement with a 3D polymer gel dosimeter for dose distributions in biological samples. Phys Med Biol 2015; 60:6531-46. [PMID: 26266894 DOI: 10.1088/0031-9155/60/16/6531] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
In this research, we used a 135 MeV/nucleon carbon-ion beam to irradiate a biological sample composed of fresh chicken meat and bones, which was placed in front of a PAGAT gel dosimeter, and compared the measured and simulated transverse-relaxation-rate (R2) distributions in the gel dosimeter. We experimentally measured the three-dimensional R2 distribution, which records the dose induced by particles penetrating the sample, by using magnetic resonance imaging. The obtained R2 distribution reflected the heterogeneity of the biological sample. We also conducted Monte Carlo simulations using the PHITS code by reconstructing the elemental composition of the biological sample from its computed tomography images while taking into account the dependence of the gel response on the linear energy transfer. The simulation reproduced the experimental distal edge structure of the R2 distribution with an accuracy under about 2 mm, which is approximately the same as the voxel size currently used in treatment planning.
Collapse
Affiliation(s)
- T Furuta
- Nuclear Science and Engineering Center, Japan Atomic Energy Agency, 2-4 Shirakata-Shirane, Tokai-mura, Ibaraki 319-1195, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Takahashi T, Asano Y, Noda S, Aozasa N, Akamata K, Taniguchi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Tada Y, Sugaya M, Kadono T, Sato S. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. Br J Dermatol 2015; 173:681-9. [PMID: 25781362 DOI: 10.1111/bjd.13779] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/09/2015] [Indexed: 12/16/2022]
Abstract
BACKGROUND Lipocalin-2 is an adipocytokine implicated in apoptosis, innate immunity, angiogenesis, and the development of chronic kidney disease. OBJECTIVES To investigate the role of lipocalin-2 in systemic sclerosis (SSc). MATERIALS AND METHODS Serum lipocalin-2 levels were determined by enzyme-linked immunosorbent assay in 50 patients with SSc and 19 healthy subjects. Lipocalin-2 expression was evaluated in the skin of patients with SSc and bleomycin (BLM)-treated mice and in Fli1-deficient endothelial cells by reverse transcriptase-real time polymerase chain reaction, immunoblotting and/or immunohistochemistry. RESULTS Although serum lipocalin-2 levels were comparable between patients with SSc and healthy controls, the prevalence of scleroderma renal crisis was significantly higher in patients with SSc with elevated serum lipocalin-2 levels than in those with normal levels. Furthermore, serum lipocalin-2 levels inversely correlated with estimated glomerular filtration rate in patients with SSc with renal dysfunction. Among patients with SSc with normal renal function, serum lipocalin-2 levels positively correlated with skin score in patients with diffuse cutaneous SSc with disease duration of < 3 years and inversely correlated with estimated right ventricular systolic pressure in total patients with SSc. Importantly, in SSc lesional skin, lipocalin-2 expression was increased in dermal fibroblasts and endothelial cells. In BLM-treated mice, lipocalin-2 was highly expressed in dermal fibroblasts, but not in endothelial cells. On the other hand, the deficiency of transcription factor Fli1, which is implicated in SSc vasculopathy, induced lipocalin-2 expression in cultivated endothelial cells. CONCLUSIONS Lipocalin-2 may be involved in renal dysfunction and dermal fibrosis of SSc. Dysregulated matrix metalloproteinase-9/lipocalin-2-dependent angiogenesis due to Fli1 deficiency may contribute to the development of pulmonary arterial hypertension associated with SSc.
Collapse
Affiliation(s)
- T Takahashi
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Y Asano
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - S Noda
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - N Aozasa
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - K Akamata
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - T Taniguchi
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Y Ichimura
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - T Toyama
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - H Sumida
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Y Kuwano
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Y Tada
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - M Sugaya
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - T Kadono
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - S Sato
- Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| |
Collapse
|
38
|
Moriuchi S, Yoshizawa S, Mizuno K, Hosoya N, Noda S, Kubota K. Effect of 1,25-dihydroxycholecalciferol on the duodenal villi and alkaline phosphatase in the developing chick embryo. Contrib Nephrol 2015; 22:9-17. [PMID: 6893176 DOI: 10.1159/000385982] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
Administration of 1,25-(OH)2D3 to developing 14-day chick embryo gave precocious induction of alkaline phosphatase in 20-day chick embryonic duodenum. 1,25-(OH)-2D3-induced alkaline phosphase involved in changes in Km and Vmax values. Furthermore, polyacrylamide gel disc electrophoresis of n-butanol-solubilized alkaline phosphatase from control and 1,25-(OH)2D3-treated chick embryonic duodenum revealed that 1,25-(OH)2D3 involved the transformation of neuraminidase-resistant fast migrating form to the neuraminidase-sensitive faster migrating one. Scanning electron microscopic data showed that the injection of 1,25-(OH)2D3 stimulated the elongation of duodenal microvilli, although there was no effect on the duodenal absorptive epithelial cell height.
Collapse
|
39
|
Kashiwagi S, Asano Y, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Maeda K, Hirakawa K. Tle3 is a Useful Marker for Predicting the Therapeutic Effect of Eribulin Chemotherapy for Triple-Negative Breast Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu326.7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
40
|
Okonogi N, Suzuki Y, Yokoo H, Ohgaki H, Sato H, Oike T, Yoshimoto Y, Noda S, Okamoto M, Nakano T. Therapeutic Impact of Intravenous-Injection of Microglia on Radiation Therapy for Malignant Glioma Arising in S100beta-v-erbB Transgenic Rat. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
41
|
Noda S, Asano Y, Kurata K, Morisaki T, Kashiwagi S, Kawajiri H, Takashima T, Onoda N, Hirakawa K. A Pilot Study to Investigate Factors to Predict the Effect of Fulvestrant 500Mg Treatment in Postmenopausal Patients with Tam or Ai-Resistant Estrogen Receptor Positive Breast Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu329.13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
42
|
Sato H, Suzuki Y, Ide M, Katoh T, Noda S, Ando K, Oike T, Yoshimoto Y, Okonogi N, Mimura K, Asao T, Kuwano H, Takashi N. HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiation Therapy in Patients With Rectal Cancer. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.1248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
43
|
Suzuki Y, Yoshimoto Y, Oike T, Okonogi N, Ando K, Sato H, Noda S, Isono M, Mimura K, Kono K, Nakano T. Carbon-Ion Beam and X-Ray Irradiation Increase a Release of an Immune Mediator Protein High Mobility Group Box 1 (HMGB1) in Various Human Cancer Cell Lines. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
44
|
Asano Y, Kashiwagi S, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Onoda N, Maeda K, Hirakawa K. Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu326.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
45
|
Taniguchi T, Asano Y, Tamaki Z, Akamata K, Aozasa N, Noda S, Takahashi T, Ichimura Y, Toyama T, Sugita M, Sumida H, Kuwano Y, Miyazaki M, Yanaba K, Sato S. Histological features of localized scleroderma ‘en coup de sabre
’: a study of 16 cases. J Eur Acad Dermatol Venereol 2013; 28:1805-10. [DOI: 10.1111/jdv.12280] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2013] [Accepted: 08/20/2013] [Indexed: 11/30/2022]
Affiliation(s)
- T. Taniguchi
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - Y. Asano
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - Z. Tamaki
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - K. Akamata
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - N. Aozasa
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - S. Noda
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - T. Takahashi
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - Y. Ichimura
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - T. Toyama
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - M. Sugita
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - H. Sumida
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - Y. Kuwano
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - M. Miyazaki
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - K. Yanaba
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| | - S. Sato
- Department of Dermatology; University of Tokyo Graduate School of Medicine; Tokyo Japan
| |
Collapse
|
46
|
Oike T, Ohno T, Noda S, Kiyohara H, Ando K, Shibuya K, Tamaki T, Takakusagi Y, Sato H, Nakano T. Can Combined Intracavitary/Interstitial Approach Be an Alternative to Interstitial Brachytherapy in Computed Tomography-Guided Adaptive Brachytherapy for Gynecological Malignancies?: A Dosimetric Study. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Noda S, Shima H, Akinaga H. Cu2O/ZnO Heterojunction Solar Cells Fabricated by Magnetron-Sputter Deposition Method Films Using Sintered Ceramics Targets. ACTA ACUST UNITED AC 2013. [DOI: 10.1088/1742-6596/433/1/012027] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
48
|
Noda S, Asano Y, Takahashi T, Akamata K, Aozasa N, Taniguchi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Yanaba K, Tada Y, Sugaya M, Kadono T, Sato S. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis. Rheumatology (Oxford) 2013; 52:790-9. [DOI: 10.1093/rheumatology/kes379] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
|
49
|
Furuta T, Ishikawa KL, Fukunishi N, Noda S, Takagi S, Maeyama T, Fukasaku K, Himeno R. Implementation of OpenMP and MPI hybrid parallelization to Monte Carlo dose simulation for particle therapy. ACTA ACUST UNITED AC 2013. [DOI: 10.1007/978-3-642-29305-4_551] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
|
50
|
Nakagawa A, Ohno T, Noda S, Kubo N, Kuwako K, Saito J, Nakano T. The Efficacy of Reducing Point A Dose in Image Guided Brachytherapy for Stage I-II Cervical Cancer of the Atrophic Small Uterus. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|